category,datetime,headline,id,image,related,source,summary,url
company,1769022163,"J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll",138207527,,BSX,DowJones,"J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll",https://finnhub.io/api/news?id=373830a3bc2b045435ca24c1834e7c01b96c1697aa87949aaded482f0883b5d2
company,1769010540,"CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February",138197266,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,CAPR said the FDA wants the full HOPE-3 study report for Deramiocel and confirmed no new clinical trials are needed.,https://finnhub.io/api/news?id=663b3ba51288ecd86ac290f16bcacb8cddb77e6dde8bf7c7ff2a3208870482b2
company,1769004180,DATAMYTE RELEASES QPS PRO TO MEET AUTOMOTIVE OEM'S INCREASING DIGITAL QUALITY REQUIREMENTS,138196012,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"ASI DATAMYTE, Inc. (""DATAMYTE""), a leading digital transformation and quality management provider to global manufacturers including Ford, GM, Stellantis, Tesla, Gillette, and Boston Scientific, today announced an enhancement to its Advanced Product Quality Planning (APQP) solution with QPS PROâ€”a centralized, fully digital system of record for APQP, Control Plans, PFMEA, DFMEA, and related quality processes that eliminates disconnected spreadsheets, paper files, and siloed systems.",https://finnhub.io/api/news?id=4a944b950cc6d04f47694fbf0344dd063c6df0831d82bcf609aaa3add93885e8
company,1769000460,Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now,138196110,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"BIO benefits from steady Clinical Diagnostics demand and international growth, but macro pressures and currency headwinds could cap near-term upside.",https://finnhub.io/api/news?id=6254e6dc1aeba114612109f8ec219a6a766e8d5eaa4b7dcd6203dfc35c48a59e
company,1769000280,Here's Why You Should Retain Revvity Stock in Your Portfolio for Now,138196111,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"Revvity's diagnostics strength and fast-growing Signals Software support long-term growth, even as macro pressures and weak funding linger.",https://finnhub.io/api/news?id=4177e47e8904d6ec193b990e19d0ee98bd4ce2b2a56e4bc5bc0fc0f90f32d649
company,1769000040,Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now?,138196112,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"IDXX rides on strong CAG Diagnostics momentum and growing global software adoption, but currency pressure and solvency risks cloud the outlook.",https://finnhub.io/api/news?id=1af633b7061e167473f8aa89ec0f59d7e1ca78e559347a34ce9d8ef6a4a1ede2
